CVS Health Corporation (NYSE:CVS) Declares $0.67 Quarterly Dividend

CVS Health Corporation (NYSE:CVS) announced a quarterly dividend on Tuesday, January 6th. Investors of record on Thursday, January 22nd will be given a dividend of 0.665 per share by the pharmacy operator on Monday, February 2nd. This represents a c) annualized dividend and a yield of 3.3%. The ex-dividend date of this dividend is Thursday, January 22nd.

CVS Health has increased its dividend payment by an average of 0.1%per year over the last three years and has increased its dividend annually for the last 4 consecutive years. CVS Health has a payout ratio of 37.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect CVS Health to earn $6.77 per share next year, which means the company should continue to be able to cover its $2.66 annual dividend with an expected future payout ratio of 39.3%.

CVS Health Stock Performance

Shares of NYSE CVS opened at $80.71 on Wednesday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63. The firm has a market cap of $102.45 billion, a price-to-earnings ratio of 212.39, a P/E/G ratio of 0.74 and a beta of 0.48. The stock’s fifty day moving average price is $78.60 and its two-hundred day moving average price is $73.65. CVS Health has a one year low of $44.92 and a one year high of $85.15.

CVS Health (NYSE:CVS) last announced its earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The company had revenue of $102.87 billion during the quarter, compared to analysts’ expectations of $98.85 billion. During the same quarter in the previous year, the business posted $1.09 earnings per share. CVS Health’s quarterly revenue was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, equities analysts forecast that CVS Health will post 5.89 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Avion Wealth boosted its stake in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock valued at $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Capital Advisors Inc. boosted its position in CVS Health by 72.1% in the third quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock valued at $26,000 after buying an additional 142 shares in the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of CVS Health by 407.2% during the third quarter. Caitong International Asset Management Co. Ltd now owns 350 shares of the pharmacy operator’s stock worth $26,000 after buying an additional 281 shares during the last quarter. Corundum Trust Company INC acquired a new position in shares of CVS Health during the third quarter worth $29,000. Finally, Harbor Asset Planning Inc. bought a new position in shares of CVS Health in the 2nd quarter valued at $30,000. Institutional investors own 80.66% of the company’s stock.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.